Functional Analysis of a Unique Troponin C Mutation, GLY159ASP, that Causes Familial Dilated Cardiomyopathy, Studied in Explanted Heart Muscle

Background—Familial dilated cardiomyopathy can be caused by mutations in the proteins of the muscle thin filament. In vitro, these mutations decrease Ca2+ sensitivity and cross-bridge turnover rate, but the mutations have not been investigated in human tissue. We studied the Ca2+-regulatory properties of myocytes and troponin extracted from the explanted heart of a patient with inherited dilated cardiomyopathy due to the cTnC G159D mutation. Methods and Results—Mass spectroscopy showed that the mutant cTnC was expressed approximately equimolar with wild-type cTnC. Contraction was compared in skinned ventricular myocytes from the cTnC G159D patient and nonfailing donor heart. Maximal Ca2+-activated force was similar in cTnC G159D and donor myocytes, but the Ca2+ sensitivity of cTnC G159D myocytes was higher (EC50 G159D/donor=0.60). Thin filaments reconstituted with skeletal muscle actin and human cardiac tropomyosin and troponin were studied by in vitro motility assay. Thin filaments containing the mutation had a higher Ca2+ sensitivity (EC50 G159D/donor=0.55±0.13), whereas the maximally activated sliding speed was unaltered. In addition, the cTnC G159D mutation blunted the change in Ca2+ sensitivity when TnI was dephosphorylated. With wild-type troponin, Ca2+ sensitivity was increased (EC50 P/unP=4.7±1.9) but not with cTnC G159D troponin (EC50 P/unP=1.2±0.1). Conclusions—We propose that uncoupling of the relationship between phosphorylation and Ca2+ sensitivity could be the cause of the dilated cardiomyopathy phenotype. The differences between these data and previous in vitro results show that native phosphorylation of troponin I and troponin T and other posttranslational modifications of sarcomeric proteins strongly influence the functional effects of a mutation.

[1]  V. Tsang,et al.  Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. , 2008, Journal of molecular and cellular cardiology.

[2]  H. Watkins,et al.  The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy , 2008, Cardiovascular research.

[3]  K. Clarke,et al.  Investigation of a mouse model of familial DCM with ACTC E361G mutation , 2008 .

[4]  W. Dong,et al.  Structural Kinetics of Cardiac Troponin C Mutants Linked to Familial Hypertrophic and Dilated Cardiomyopathy in Troponin Complexes* , 2008, Journal of Biological Chemistry.

[5]  Yves F Dufrêne,et al.  High-resolution cell surface dynamics of germinating Aspergillus fumigatus conidia. , 2008, Biophysical journal.

[6]  P. J. Griffiths,et al.  Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and &agr;-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments , 2007, Circulation research.

[7]  P. Elliott,et al.  Mutations in the cardiac Troponin C gene are a cause of idiopathic dilated cardiomyopathy in childhood , 2007, Cardiology in the Young.

[8]  W. Paulus,et al.  Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies , 2007, Proteomics. Clinical applications.

[9]  C. Redwood,et al.  DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation. , 2007, Biochemical and biophysical research communications.

[10]  Yuan-yuan Wang,et al.  Knock-In Mouse Model of Dilated Cardiomyopathy Caused by Troponin Mutation , 2007, Circulation research.

[11]  G. Boivin,et al.  Dilated Cardiomyopathy Mutant Tropomyosin Mice Develop Cardiac Dysfunction With Significantly Decreased Fractional Shortening and Myofilament Calcium Sensitivity , 2007, Circulation research.

[12]  P. D. de Tombe,et al.  The Troponin C G159D Mutation Blunts Myofilament Desensitization Induced by Troponin I Ser23/24 Phosphorylation , 2007, Circulation research.

[13]  H. Watkins,et al.  The Effect of Mutations in α-Tropomyosin (E40K and E54K) That Cause Familial Dilated Cardiomyopathy on the Regulatory Mechanism of Cardiac Muscle Thin Filaments* , 2007, Journal of Biological Chemistry.

[14]  H. Watkins,et al.  Functional effects of the DCM mutant Gly159Asp Troponin C in skinned muscle fibres , 2007, Pflügers Archiv - European Journal of Physiology.

[15]  M. Gautel,et al.  Activation of Myocardial Contraction by the N-Terminal Domains of Myosin Binding Protein-C , 2006, Circulation research.

[16]  J. Potter,et al.  Functional Consequences of Hypertrophic and Dilated Cardiomyopathy-causing Mutations in α-Tropomyosin* , 2005, Journal of Biological Chemistry.

[17]  J. Potter,et al.  Sarcomeric Protein Mutations in Dilated Cardiomyopathy , 2005, Heart Failure Reviews.

[18]  H. Watkins,et al.  Dilated Cardiomyopathy Mutations in Three Thin Filament Regulatory Proteins Result in a Common Functional Phenotype* , 2005, Journal of Biological Chemistry.

[19]  M. Antognozzi,et al.  Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells. , 2005, American journal of physiology. Heart and circulatory physiology.

[20]  H. Watkins,et al.  Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[21]  K. Jaquet,et al.  Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways. , 2003, Journal of molecular and cellular cardiology.

[22]  Steven R Houser,et al.  Is depressed myocyte contractility centrally involved in heart failure? , 2003, Circulation research.

[23]  H. Watkins,et al.  Alterations in Thin Filament Regulation Induced by a Human Cardiac Troponin T Mutant That Causes Dilated Cardiomyopathy Are Distinct from Those Induced by Troponin T Mutants That Cause Hypertrophic Cardiomyopathy* , 2002, The Journal of Biological Chemistry.

[24]  Steven B Marston,et al.  In vitro motility analysis of thin filaments from failing and non-failing human heart: troponin from failing human hearts induces slower filament sliding and higher Ca(2+) sensitivity. , 2002, Journal of molecular and cellular cardiology.

[25]  B. Brenner,et al.  Mutation of the myosin converter domain alters cross-bridge elasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Jaquet,et al.  Effects of phosphorylation and mutation R145G on human cardiac troponin I function. , 2001, Biochemistry.

[27]  C. Lim,et al.  High-throughput assessment of calcium sensitivity in skinned cardiac myocytes. , 2001, American journal of physiology. Heart and circulatory physiology.

[28]  D. Szczesna,et al.  Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. , 2001, The Journal of biological chemistry.

[29]  S. Solomon,et al.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.

[30]  N. Weissman,et al.  Inotropic Stimulation Induces Cardiac Dysfunction in Transgenic Mice Expressing a Troponin T (I79N) Mutation Linked to Familial Hypertrophic Cardiomyopathy* , 2001, The Journal of Biological Chemistry.

[31]  H. Watkins,et al.  Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein. , 2000, Circulation research.

[32]  M. Raida,et al.  Variability in the ratio of mutant to wildtype myosin heavy chain present in the soleus muscle of patients with familial hypertrophic cardiomyopathy. A new approach for the quantification of mutant to wildtype protein , 1999, FEBS letters.

[33]  Steven B Marston,et al.  Functional analysis of human cardiac troponin by the in vitro motility assay: comparison of adult, foetal and failing hearts. , 1999, Cardiovascular research.

[34]  C. Visser,et al.  Force production in mechanically isolated cardiac myocytes from human ventricular muscle tissue. , 1998, Cardiovascular research.

[35]  I. Fraser,et al.  In Vitro Motility Analysis of Actin-Tropomyosin Regulation by Troponin and Calcium , 1995, The Journal of Biological Chemistry.

[36]  F. Reinach,et al.  Functional alpha-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group. , 1994, The Journal of biological chemistry.

[37]  Steven B Marston,et al.  Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. , 2007, Journal of molecular and cellular cardiology.

[38]  Steven B Marston,et al.  Cardiac and skeletal myopathies: can genotype explain phenotype? , 2004, Journal of Muscle Research & Cell Motility.

[39]  Steven B Marston.  Random walks with thin filaments: application of in vitro motility assay to the study of actomyosin regulation , 2004, Journal of Muscle Research & Cell Motility.

[40]  Z. Papp,et al.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. , 2003, Cardiovascular research.